Compound Detail
CHEMBL666
FOSCARNET 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL666 |
| Name | FOSCARNET |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ZJAOAACCNHFJAH-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
12
Targets
89
Activities
4
Assay Types
10
PK Parameters
20
Publications
3
Known Names
3
Indications
Molecular Properties
126.0
MW (Da)
-0.16
ALogP
2
HBA
3
HBD
94.8
PSA (Ų)
0.42
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1991 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Virus Diseases Cytomegalovirus Infections Cytomegalovirus Retinitis
ATC Classification
J05AD01
foscarnet
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE
Activity Summary
IC50 43 meas. best 6.1
EC50 40 meas. best 4.96
Ki 4 meas.
Kd 2 meas. best 6.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | Kd | 6.4 | 5.63 | 400.0 | 2 |
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | IC50 | 6.1 | 5.3571 | 800.0 | 7 |
| Unchecked CHEMBL612545 | IC50 | 5.89 | 5.5783 | 1300.0 | 6 |
| DNA polymerase catalytic subunit CHEMBL3414 | IC50 | 5.6 | 5.6 | 2500.0 | 2 |
| Human betaherpesvirus 5 CHEMBL371 | IC50 | 5.16 | 4.3923 | 7000.0 | 13 |
| Human betaherpesvirus 5 CHEMBL371 | EC50 | 4.96 | 4.583 | 11000.0 | 10 |
| HFF CHEMBL614071 | IC50 | 4.41 | 4.205 | 39000.0 | 2 |
| Mus musculus CHEMBL375 | EC50 | 4.37 | 4.37 | 42800.0 | 1 |
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 4.36 | 4.36 | 44000.0 | 1 |
| Human alphaherpesvirus 1 CHEMBL377 | IC50 | 4.34 | 4.265 | 46000.0 | 2 |
| HEL CHEMBL613888 | EC50 | 4.28 | 4.245 | 53000.0 | 2 |
| HeLa CHEMBL399 | EC50 | 4.19 | 4.19 | 65000.0 | 1 |
| Human alphaherpesvirus 2 CHEMBL370 | EC50 | 4.12 | 4.0525 | 76000.0 | 4 |
| MT4 CHEMBL388 | EC50 | 4.06 | 4.06 | 87000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 2.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 2.1 | mL.min-1.kg-1 | Homo sapiens |
| F | 17.0 | % | Homo sapiens |
| Fu | 0.85 | - | Homo sapiens |
| Fu | 0.85 | - | Homo sapiens |
| KA | 12.0 | uM | Homo sapiens |
| MRT | 4.0 | hr | Homo sapiens |
| T1/2 | 4.7 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 228 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 20733037 | 10.1128/aac.00669-10 | Human alphaherpesvirus 2 | 14 |
| 15916444 | 10.1021/jm049059x | Mus musculus | 13 |
| 17043128 | 10.1128/aac.00633-06 | Human betaherpesvirus 5 | 13 |
| 17709468 | 10.1128/aac.00736-07 | Human betaherpesvirus 5 | 12 |
| 20733037 | 10.1128/aac.00669-10 | Human alphaherpesvirus 1 | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 17145704 | 10.1074/jbc.m607710200 | Human immunodeficiency virus type 1 reverse transcriptase | 9 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 19226140 | 10.1021/jm8014662 | Human betaherpesvirus 5 | 8 |
| 18707089 | 10.1021/jm800050t | Human betaherpesvirus 5 | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 2842506 | 10.1021/jm00117a026 | Human alphaherpesvirus 1 | 8 |
| 25144111 | 10.1021/jm501010f | Human immunodeficiency virus type 1 reverse transcriptase | 7 |
| 19010684 | 10.1016/j.bmc.2008.10.081 | Human alphaherpesvirus 1 | 6 |
| 15658873 | 10.1021/jm049711o | ADMET | 5 |
| 19770274 | 10.1128/aac.00417-09 | Human alphaherpesvirus 2 | 4 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
Data from ChEMBL 36 via Core Engine